ibudilast has been researched along with roflumilast in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, J; Ke, H; Peng, T; Qi, B; Shi, J | 1 |
| Bass, CR; Meaney, DF; Morales, FN; Morrison, B; Vogel, EW | 1 |
1 review(s) available for ibudilast and roflumilast
| Article | Year |
|---|---|
Advances in the Development of Phosphodiesterase-4 Inhibitors.
Topics: Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Development; Drug Discovery; Humans; Molecular Structure; Phosphodiesterase 4 Inhibitors; Protein Conformation; Quinolones; Vomiting | 2020 |
1 other study(ies) available for ibudilast and roflumilast
| Article | Year |
|---|---|
Phosphodiesterase-4 inhibition restored hippocampal long term potentiation after primary blast.
Topics: Aminopyridines; Animals; Animals, Newborn; Benzamides; Blast Injuries; Cell Death; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Disease Models, Animal; Disks Large Homolog 4 Protein; Gene Expression Regulation; Glycine; Guanylate Kinases; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Membrane Proteins; Papaverine; Phosphodiesterase 4 Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Time Factors | 2017 |